These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 15453681)

  • 1. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
    Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
    J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eluent pH on the HPLC-UV analysis of hyperforin from St. John's Wort (Hypericum perforatum L.).
    Fourneron JD; Naït-Si Y
    Phytochem Anal; 2006; 17(2):71-7. PubMed ID: 16634282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin.
    Sleno L; Daneshfar R; Eckert GP; Müller WE; Volmer DA
    Rapid Commun Mass Spectrom; 2006; 20(18):2641-8. PubMed ID: 16912989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U; Likussar W; Michelitsch A
    Phytochem Anal; 2007; 18(3):204-8. PubMed ID: 17500362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
    Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
    Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study.
    Muruganandam AV; Bhattacharya SK; Ghosal S
    Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
    Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG; Gray DE; Rottinghaus GE; Garrett HE; Pallardy SG
    J AOAC Int; 2000; 83(4):944-9. PubMed ID: 10995119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography-mass spectrometry studies of St. John's wort methanol extraction: active constituents and their transformation.
    Liu F; Pan C; Drumm P; Ang CY
    J Pharm Biomed Anal; 2005 Feb; 37(2):303-12. PubMed ID: 15708671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatographic determination of St. John's wort components in functional foods.
    de Jager LS; Perfetti GA; Diachenko GW
    J AOAC Int; 2004; 87(5):1042-8. PubMed ID: 15493659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L; Appendino G; Jakupovic J; Bombardelli E
    J Nat Prod; 2000 Mar; 63(3):412-5. PubMed ID: 10757735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first prenylation step in hyperforin biosynthesis.
    Boubakir Z; Beuerle T; Liu B; Beerhues L
    Phytochemistry; 2005 Jan; 66(1):51-7. PubMed ID: 15649510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts.
    Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S
    Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of the hyperforin skeleton in Hypericum calycinum cell cultures.
    Klingauf P; Beuerle T; Mellenthin A; El-Moghazy SA; Boubakir Z; Beerhues L
    Phytochemistry; 2005 Jan; 66(2):139-45. PubMed ID: 15652570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of St. John's wort components in dietary supplements and functional foods by liquid chromatography.
    Ang CY; Cui Y; Chang HC; Luo W; Heinze TM; Lin LJ; Mattia A
    J AOAC Int; 2002; 85(6):1360-9. PubMed ID: 12477200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
    Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
    Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.